Abstract:
Bipolar I Disorder (BD-I) is a severe mental illness characterized by recurrent
manic, depressive, and hypomanic episodes, affecting approximately 1% of the global
population. While pharmacological treatments often achieve symptomatic remission, functional
recovery consistently lags behind, with studies reporting that up to 60% of patients remain
functionally impaired even during euthymic periods. However, limited research has specifically
examined BD-I and its associated factors.